Abstract
We found that 1,5-anhydroglucitol—a marker of glucose excursions—was not independently
associated with subclinical cardiac damage, nor with vascular outcomes, in the ADVANCE
Trial. High-sensitivity cardiac troponin T and N-terminal pro-b-type natriuretic peptide
provided better prognostic information regarding vascular risk in diabetes than 1,5-anhydroglucitol.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Diabetes Research and Clinical PracticeAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
Reference
- Glycaemic variability in diabetes: clinical and therapeutic implications.Lancet Diabetes Endocrinol. 2019; 7: 221-230
- Glycemic variability and cardiovascular disease in patients with type 2 diabetes.BMJ Open Diabetes Res Care. 2021; 9: e002032https://doi.org/10.1136/bmjdrc-2020-002032
- Response of 1,5-anhydroglucitol level to intensive glucose- and blood-pressure lowering interventions, and its associations with clinical outcomes in the ADVANCE trial.Diabetes Obes Metab. 2019; 21: 2017-2023
- Association of 1,5-anhydroglucitol with cardiovascular disease and mortality.Diabetes. 2016; 65: 201-208
- Association of a biomarker of glucose peaks, 1,5-anhydroglucitol, with subclinical cardiovascular disease.Diabetes Care. 2016; 39: 1752-1759
- Serum 1,5-anhydro-D-glucitol levels predict first-ever cardiovascular disease: an 11-year population-based cohort study in Japan, the Suita study.Atherosclerosis. 2011; 216: 477-483
- Cardiovascular disease and 1,5-anhydro-d-glucitol.Glob Health Med. 2019; 1: 83-87
- Impact of serum 1,5-anhydro-d-glucitol level on prediction of major adverse cardiac and cerebrovascular events in non-diabetic patients without coronary artery disease.Atherosclerosis. 2016; 253: 1-6
- Low 1,5-anhydroglucitol levels are associated with long-term cardiac mortality in acute coronary syndrome patients with hemoglobin A1c levels less than 7.0.Cardiovasc Diabetol. 2017; 16https://doi.org/10.1186/s12933-017-0636-1
- Serum 1,5-Anhydroglucitol: Risk Factor of Acute Ischemic Stroke and Transient Ischemic Attack in Well-Controlled Diabetes.Cerebrovasc Diseases (Basel, Switzerland). 2017; 44: 325-329
- High-sensitivity cardiac Troponin I and T for cardiovascular risk stratification in adults with diabetes.Diabetes Care. 2020; 43: e144-e146
- Natriuretic peptide and high-sensitivity troponin for cardiovascular risk prediction in diabetes: the atherosclerosis risk in communities (ARIC) study.Diabetes Care. 2016; 39: 677-685
- Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.New England J Med. 2008; 358: 2560-2572
- Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.Lancet (London, England). 2007; 370: 829-840
- 1,5-anhydroglucitol and postprandial hyperglycemia as measured by continuous glucose monitoring system in moderately controlled patients with diabetes.Diabetes Care. 2006; 29: 1214-1219
- Comparison of two assays for serum 1,5-anhydroglucitol.Clin Chim Acta; Int J Clin Chem. 2011; 412: 793-795
- One-year in vitro stability of cardiac troponins and galectin-3 in different sample types.Clin Chim Acta; Int J Clin Chem. 2018; 476: 117-122
- Two-year stability of NT-proBNP in frozen samples using the Roche Elecsys system.Ann Clin Biochem. 2008; 45: 318-319
- Amino-terminal pro-B-type natriuretic peptide: analytic considerations.Am J Cardiol. 2008; 101: S9-S15
Article info
Publication history
Published online: November 17, 2021
Accepted:
November 15,
2021
Received in revised form:
October 27,
2021
Received:
June 23,
2021
Identification
Copyright
© 2021 Elsevier B.V. All rights reserved.
